Skip to content

Clinical trials

Phase 2 Scleroderma, Systemic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Phase: Phase 2 Country / region: France Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20121
20131
20142
20152
20161
20171
20202
20222
20231
20241
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting6
Not yet recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assistance Publique - Hôpitaux de Paris4
Assistance Publique Hopitaux De Marseille2
Sanofi2
University Hospital, Toulouse2
Actelion1
Artiva Biotherapeutics, Inc.1
Bayer1
Boehringer Ingelheim1
Celgene1
Heidelberg University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic21
Arthritis, Rheumatoid2
Scleroderma, Diffuse2
Aortic Arch Syndromes1
Behcet Syndrome1
Cholangitis, Sclerosing1
Colitis, Ulcerative1
Crohn Disease1
Dermatomyositis1
Familial Primary Pulmonary Hypertension1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.